A patient has been evaluated for a coagulopathy, and has been given Coumadin as a mode of treatment.What screening test(s) should be performed to monitor this treatment, and what effect will this therapy have on the coagulation pathway?
A) APTT; initial decrease in the vitamin K-dependent factors of the intrinsic pathway
B) PT-INR; initial decrease in the vitamin K-dependent factors of the extrinsic pathway
C) PT-INR and APTT; initial decrease in the vitamin K-dependent factors of all pathways
D) PT-INR; initial decrease in all Vitamin K-dependent serine proteases
Correct Answer:
Verified
Q2: A patient has been taking coumadin for
Q5: A tendency to favor thrombus formation that
Q6: How do unfractionated heparin and low-molecular weight
Q8: During coumadin-induced anticoagulation, which factor's activity disappears
Q8: How does heparin inhibit coagulation?
A)It chelates calcium
Q11: A 30-year-old patient is diagnosed with a
Q14: Patients with a DVT are at risk
Q15: Mutations in which of the following gene(s)
Q19: Patients with protein C and/or S deficiencies
Q28: Name the genetic mutation that induces increased
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents